This narrative review synthesizes existing literature on the management and treatment of dry eye disease (DED) following LASIK refractive surgery.
Frontiers in Medicine · 13 authors, 11 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review synthesizes existing literature on the management and treatment of dry eye disease (DED) following LASIK refractive surgery.
This narrative review examines the management and treatment of dry eye disease (DED) following laser-assisted in situ keratomileusis (LASIK) and other refractive surgeries. The authors describe DED as the most common post-LASIK complication, noting that nearly all patients develop some degree of postoperative dryness that can persist for up to one year or become chronic. The review covers differences in DED incidence across surgical techniques, reporting that SMILE shows better DED recovery than femtosecond laser (FS) and microkeratome (MK) approaches within the first three months. Therapeutic options discussed include preservative-free artificial tears, punctal plugs, autologous serum, cyclosporine, scleral lenses, and oral medications. The authors emphasize that preoperative detection and treatment of existing DED is the most significant factor in reducing postoperative complications.